Access cutting-edge urothelial cancer treatment through this clinical trial at a research site in Rogers. Study-provided care at no cost to qualified participants.
Access urothelial cancer specialists in Rogers at no cost
This study follows strict safety protocols and ethical guidelines
All study-related urothelial cancer treatment provided free
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this urothelial cancer clinical trial in Rogers, AR
If you're searching for urothelial cancer treatment options in Rogers, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rogers research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urothelial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.